2. Kim Z, Min SY, Yoon CS, Jung KW, Ko BS, Kang E, et al. The basic facts of Korean breast cancer in 2012: Results from a nationwide survey and breast cancer registry database. J Breast Cancer. 2015; 18(2):103–111.
Article
4. Kim KH, Chung BY, Kim GD, Byun HS, Choi EH, Cho EJ. Cognitive function in breast cancer patients receiving adjuvant chemotherapy. Asian Oncol Nurs. 2012; 12(1):1–11.
Article
5. Ko HK, Park GJ. Effects of self-efficacy promotion program on self-efficacy, self-care behavior, and quality of life in breast cancer patients receiving radiotherapy. Asian Oncol Nurs. 2011; 11(2):136–146.
Article
6. Duijts SF, Faber MM, Oldenburg HS, van Beurden M, Aaronson NK. Effectiveness of behavioral techniques and physical exercise on psychosocial functioning and health-related quality of life in breast cancer patients and survivors. a meta-analysis. Psychooncology. 2011; 20:115–126.
Article
7. Boehmke MM, Dickerson SS. Symptom, symptom experiences, and symptom distress encountered by women with breast cancer undergoing current treatment modalities. Cancer Nurs. 2005; 28(5):382–389.
Article
8. Viale PH, Yamamoto DS. Cardiovascular toxicity associated with cancer treatment. Clin J Oncol Nurs. 2008; 12(4):627–638.
Article
9. Smith LA, Cornelius VR, Plummer CJ, Levitt G, Verrill M, Canney P, et al. Cardiotoxicity of anthracycline agents for the treatment of cancer: systematic review and meta-analysis of randomised controlled trials. BMC Cancer. 2010; 10:337.
Article
10. Darby SC, McGale P, Taylor CW, Peto R. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol. 2005; 6(8):557–565.
Article
11. Tian S, Hirshfield KM, Jabbour SK, Toppmeyer D, Haffty BG, Khan AJ, et al. Serum biomarkers for the detection of cardiac toxicity after chemotherapy and radiation therapy in breast cancer patients. Front Oncol. 2014; 4:277.
Article
12. Sabel MS, Levine EG, Hurd T, Schwartz GN, Zielinski R, Hohn D, et al. Is MUGA scan necessary in patients with low-risk breast cancer before doxorubicin-based adjuvant therapy? Multiple gated acquisition. Am J Clin Oncol. 2001; 24(4):425–428.
Article
13. Sturgeon KM, Ky B, Libonati JR, Schmitz KH. The effects of exercise on cardiovascular outcomes before, during, and after treatment for breast cancer. Breast Cancer Res Treat. 2014; 143(2):219–226.
Article
14. U.S. National Institutes of Health. U.S. National Library of Medicine. Clinical trials.gov;Accessed Nov 12, 2015.
https://clinicaltrials.gov.
15. Haykowsky MJ, Mackey JR, Thompson RB, Jones LW, Paterson DI. Adjuvant trastuzumab induces ventricular remodeling despite aerobic exercise training. Clin Cancer Res. 2009; 15(15):4963–4967.
Article
16. Kolden GG, Strauman TJ, Ward A, Kuta J, Woods TE, Schneider KL, et al. A pilot study of group exercise training (GET) for women with primary breast cancer: feasibility and health benefits. Psychooncology. 2002; 11(5):447–456.
Article
17. Kim CW, Kim YS, Kim YS, Kim KC, Kim HE. The effect of tai-chi exercise on the function of shoulder joint, heart rate in breast cancer patients. J Life Sci. 2010; 20(3):345–349.
Article
18. Hwang IS, Kwak YS. Tai chi exercise on MDA, SOD and physical fitness in breast cancer patients. J Life Sci. 2009; 19(4):543–548.
Article
19. Eom A. Effects of a taichi program for early mastectomy patients. Korean J Women Health Nurs. 2007; 13(1):43–50.
Article
20. Kim CJ, Kang DH, Smith BA, Landers KA. Cardiopulmonary responses and adherence to exercise in women newly diagnosed with breast cancer undergoing adjuvant therapy. Cancer Nurs. 2006; 29(2):156–165.
Article
21. Kim MS, Yang JH. Effects of yoga and walking on pulmonary function, hemoglobin and platelet patients receiving chemotherapy and radiation therapy after mastectomy. Korean J Phys Educ. 2006; 45(1):675–685.
23. Kolloch R, Legler UF, Champion A, Cooper-Dehoff RM, Handberg E, Zhou Q, et al. Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: findings from the INternational VErapamil-SR/trandolapril STudy (INVEST). Eur Heart J. 2008; 29(10):1327–1334.
Article
24. Fox K, Ford I, Steg PG, Tendera M, Robertson M, Ferrari R. Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial. Lancet. 2008; 372(9641):817–821.
Article
25. Hambrecht R, Gielen S, Linke A, Fiehn E, Yu J, Walther C, et al. Effects of exercise training on left ventricular function and peripheral resistance in patients with chronic heart failure: a randomized trial. JAMA. 2000; 283(23):3095–3101.
Article
26. Lawes CM, Vander Hoorn S, Rodgers A. Global burden of blood-pressure-related disease, 2001. Lancet. 2008; 371(9623):1513–1518.
Article
27. Lee KW, Kim KR, Lee JS. The effects of 12-week combined exercise program on body composition, pulse wave velocity, blood nitric oxide and lipids in middle-aged women with pre-hypertension. J Sport Leis Stud. 2014; 58(2):923–934.
Article
28. Cardinale D, Sandri MT, Colombo A, Colombo N, Boeri M, Lamantia G, et al. Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy. Circulation. 2004; 109(22):2749–2754.
Article
29. Romano S, Fratini S, Ricevuto E, Procaccini V, Stifano G, Mancini M, et al. Serial measurements of NT-proBNP are predictive of not-high-dose anthracycline cardiotoxicity in breast cancer patients. Br J Cancer. 2011; 105(11):1663–1668.
Article
30. Kim EM. The effects of exercise program for post-op breast cancer survivors: a meta-analysis [master's thesis]. Gangwon: Kangwon Univ;2013.